1138 related articles for article (PubMed ID: 32581081)
1. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
Simmonds P
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
[TBL] [Abstract][Full Text] [Related]
2. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus genomes carry the signatures of their habitats.
Wei Y; Silke JR; Aris P; Xia X
PLoS One; 2020; 15(12):e0244025. PubMed ID: 33351847
[TBL] [Abstract][Full Text] [Related]
4. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
Ratcliff J; Simmonds P
Virology; 2021 Apr; 556():62-72. PubMed ID: 33545556
[TBL] [Abstract][Full Text] [Related]
5. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
Matyášek R; Kovařík A
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646049
[TBL] [Abstract][Full Text] [Related]
6. The substitution spectra of coronavirus genomes.
Forni D; Cagliani R; Pontremoli C; Clerici M; Sironi M
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34518866
[TBL] [Abstract][Full Text] [Related]
7. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
Kosuge M; Furusawa-Nishii E; Ito K; Saito Y; Ogasawara K
Sci Rep; 2020 Oct; 10(1):17766. PubMed ID: 33082451
[TBL] [Abstract][Full Text] [Related]
8. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
Di Giorgio S; Martignano F; Torcia MG; Mattiuz G; Conticello SG
Sci Adv; 2020 Jun; 6(25):eabb5813. PubMed ID: 32596474
[TBL] [Abstract][Full Text] [Related]
9. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive comparative genomic and microsatellite analysis of SARS, MERS, BAT-SARS, and COVID-19 coronaviruses.
Rehman HA; Ramzan F; Basharat Z; Shakeel M; Khan MUG; Khan IA
J Med Virol; 2021 Jul; 93(7):4382-4391. PubMed ID: 33782990
[TBL] [Abstract][Full Text] [Related]
11. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
Front Immunol; 2020; 11():1949. PubMed ID: 32849654
[TBL] [Abstract][Full Text] [Related]
12. Coronaviruses and SARS-COV-2.
Hasöksüz M; Kiliç S; Saraç F
Turk J Med Sci; 2020 Apr; 50(SI-1):549-556. PubMed ID: 32293832
[TBL] [Abstract][Full Text] [Related]
13. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
14. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
Simmonds P
mBio; 2020 Oct; 11(6):. PubMed ID: 33127861
[TBL] [Abstract][Full Text] [Related]
15. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
16. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
[TBL] [Abstract][Full Text] [Related]
17. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
Gautam A; Kaphle K; Shrestha B; Phuyal S
Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
[TBL] [Abstract][Full Text] [Related]
19. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167
[TBL] [Abstract][Full Text] [Related]
20.
Llanes A; Restrepo CM; Caballero Z; Rajeev S; Kennedy MA; Lleonart R
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
